Here's a list of Indian agritech startups, showcasing the innovative strides they are making in transforming the agricultural ...
Imagine taking a single photo of a person and, within seconds, seeing them talk, gesture, and even perform—without ever recording a real video. That is the power of ByteDance’s OmniHuman-1. The ...
Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback